8 completed, 1 recruiting, 1 unknown. 10 Phase 1, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 10 | Completed 8, Recruiting 1, Unknown 1 |
| Phase 2 | 5 | Completed 4, Unknown 1 |
Follow Dry Eye Syndrome: new trials by email Literature Review of Dry Eye Syndrome trials Research Report on Dry Eye Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA) ABBV-319 - Dry Eye Syndrome, Systemic Lupus Erythematosus | Phase 1 | Recruiting | AbbVie | 36 | 2025-08-26 | 2026-08-10 |
| A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease AGN-242428, AGN-231868, AGN-242428 Vehicle - Dry Eye Disease, Dry Eye Syndrome | Phase 1 / Phase 2 | Completed | AbbVie | 292 | 2020-03-04 | 2025-05-20 |
| Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease SJP-0132, Placebo - Dry Eye Disease, Dry Eye Syndrome | Phase 1 / Phase 2 | Completed | Senju Pharmaceutical Co., Ltd. | 89 | 2019-10-05 | 2023-04-20 |
| Assessing the Safety and Efficacy of AVX-012 in Subjects With Mild-to-moderate Dry Eye Syndrome AVX012 Ophthalmic Solution Low dose, AVX012 Ophthalmic Solution High dose, Placebo (vehicle) - Dry Eye Syndrome | Phase 1 / Phase 2 | Unknown | Avizorex Pharma, S.L. | 172 | 2017-04-03 | 2018-10-01 |
| Study of ST266 Eye Drops in Treating Dry Eye ST266, Refresh Lubricant Eye Drops - Dry Eye Syndrome | Phase 1 | Completed | Noveome Biotherapeutics, formerly Stemnion | 30 | 2015-03-01 | 2019-05-13 |
| Safety and Efficacy of PG101 for Dry Eye Syndrome PG101 - Dry Eye Syndrome | Phase 1 / Phase 2 | Completed | Rhodes Pharmaceuticals, L.P. | 72 | 2013-12-01 | 2014-03-05 |
| Pilot Study to Evaluate SYL1001 Safety and Effect in Patients With Ocular Pain SYL1001, Placebo - Ocular Pain, Dry Eye Syndrome | Phase 1 / Phase 2 | Completed | Sylentis, S.A. | 60 | 2012-11-01 | 2015-05-25 |
| A Multi-Center Study Subjects With Dry Eye Syndrome EBI-005-2 - Dry Eye Syndrome | Phase 1 | Completed | Eleven Biotherapeutics | 74 | 2012-11-01 | 2013-08-14 |
| Assessment of Safety and Tolerability of Chitosan-N-acetylcysteine Eye Drops in Subjects While Wearing Contact Lenses and Before Insertion of Contact Lenses Chitosan-N-acetylcysteine eye drops (concentration of 0.1%), Physiological saline solution - Dry Eye Syndrome | Phase 1 | Completed | Medical University of Vienna | 48 | 2011-07-01 | 2012-12-11 |
| Phase I Study to Evaluate the Tolerability of Eye Drop DA-6034 in Healthy Volunteers DA-6034, Placebo - Dry Eye Syndrome | Phase 1 | Completed | Dong-A ST Co., Ltd. | 2008-09-01 | 2014-10-01 |
Dry Eye Syndromes (10) · Eye Pain (1) · Keratoconjunctivitis Sicca (1) · Lupus Erythematosus, Systemic (1)
Eye Diseases (10) · Lacrimal Apparatus Diseases (10) · Autoimmune Diseases (1) · Conjunctival Diseases (1) · Conjunctivitis (1) · Connective Tissue Diseases (1) · Corneal Diseases (1) · Eye Manifestations (1) · Immune System Diseases (1) · Keratitis (1) · Keratoconjunctivitis (1) · Neurologic Manifestations (1) · Pain (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Gels (1) · Ophthalmic Solutions (1) · lifitegrast (1) · recoflavone (1)
AbbVie (2) · Avizorex Pharma, S.L. (1) · Dong-A ST Co., Ltd. (1) · Eleven Biotherapeutics (1) · Medical University of Vienna (1) · Noveome Biotherapeutics, formerly Stemnion (1) · Rhodes Pharmaceuticals, L.P. (1) · Senju Pharmaceutical Co., Ltd. (1) · Sylentis, S.A. (1)
United States (6) · Spain (2) · Austria (1) · France (1) · Netherlands (1) · South Korea (1)
David Steed, MD (1) · Gail Torkildsen, M.D. (1) · Kathy Kelley, OD (1) · Kyung-Sang Yu, M.D., Ph.D., M.B.A (1) · Michael Goldstein, MD (1) · Patrick Tresserras (1)
2016 (1)